BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25429762)

  • 1. Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.
    Li L; Wei Y; To C; Zhu CQ; Tong J; Pham NA; Taylor P; Ignatchenko V; Ignatchenko A; Zhang W; Wang D; Yanagawa N; Li M; Pintilie M; Liu G; Muthuswamy L; Shepherd FA; Tsao MS; Kislinger T; Moran MF
    Nat Commun; 2014 Nov; 5():5469. PubMed ID: 25429762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
    Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
    Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive lung cancer determined by expression profiling and transcriptional regulation.
    Han N; Dol Z; Vasieva O; Hyde R; Liloglou T; Raji O; Brambilla E; Brambilla C; Martinet Y; Sozzi G; Risch A; Montuenga LM; ; Brass A; Field JK
    Int J Oncol; 2012 Jul; 41(1):242-52. PubMed ID: 22469662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
    Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
    Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches.
    Zhang W; Wei Y; Ignatchenko V; Li L; Sakashita S; Pham NA; Taylor P; Tsao MS; Kislinger T; Moran MF
    Proteomics; 2014 Mar; 14(6):795-803. PubMed ID: 24453208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
    Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
    Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
    Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
    Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
    Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
    Bastide K; Ugolin N; Levalois C; Bernaudin JF; Chevillard S
    Lung Cancer; 2010 Apr; 68(1):1-9. PubMed ID: 20004040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.
    Tan M; Song X; Zhang G; Peng A; Li X; Li M; Liu Y; Wang C
    Oncol Rep; 2013 Oct; 30(4):1639-44. PubMed ID: 23842884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dentin matrix protein 1 is expressed in human lung cancer.
    Chaplet M; De Leval L; Waltregny D; Detry C; Fornaciari G; Bevilacqua G; Fisher LW; Castronovo V; Bellahcène A
    J Bone Miner Res; 2003 Aug; 18(8):1506-12. PubMed ID: 12929940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression.
    Sheng KL; Kang L; Pridham KJ; Dunkenberger LE; Sheng Z; Varghese RT
    Sci Rep; 2020 Dec; 10(1):21246. PubMed ID: 33277589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
    Sun Z; Wigle DA; Yang P
    J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
    Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
    Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
    Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
    J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.